Home › Agenda › ESH-ICMLF International Conference Chronic Myeloid Leukemia - Biological Basis of Therapy ESH-ICMLF International Conference Chronic Myeloid Leukemia - Biological Basis of Therapy 24/09/2010 - 26/09/2010
Washington DC, EUA
Despite the impressive clinical results of tyrosine kinase inhibitors in the management of patients with CML, many unresolved questions remain. This meeting brings together scientists with new data on the cellular, molecular and immune biology of CML, some of which may eventually translate into new therapeutic approaches that would enable the clinician to discontinue therapy with the expectation that the leukaemia would not recur.
Mais informações aqui.